Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.71 |
| ▸ | DNM1 | Q05193 | 10/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.56 |
| ▸ | RAD52 | P43351 | 2/20 | 0.56 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.52 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL29166554 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL29166978 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL28622942 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL28635700 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL1462860 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL29166546 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL28640480 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Didecyldimethylammonium SCHEMBL2311559 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL29166854 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL28623070 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107209146-B | Electrochemical gas sensor and electrolyte for electrochemical gas sensor | 德尔格安全股份两合公司 | 2024-03-12 | — | — | CN | disclosed |
| EP-3135677-B1 | ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING SAME, AND USE FOR SAME | JX NIPPON OIL & ENERGY CORP (JP) | 2018-10-10 | — | — | EP | disclosed |
| US-9695186-B2 | Alicyclic diepoxy compound having bis-spironorbornane structure, method for producing the same, and use thereof | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2017-07-04 | — | — | US | disclosed |
| EP-3135677-A1 | ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING SAME, AND USE FOR SAME | JX Nippon Oil & Energy Corporation (JP) | 2017-03-01 | — | — | EP | disclosed |
| US-20170044179-A1 | ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE THEREOF | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2017-02-16 | — | — | US | disclosed |
| US-20160074856-A1 | RECOVERY METHOD AND REUSE METHOD OF OXO ACID CATALYST | DAICEL CORPORATION (JP) | 2016-03-17 | — | — | US | disclosed |
| EP-2990110-A1 | RECOVERY METHOD AND REUSE METHOD OF OXO ACID CATALYST | Daicel Corporation (JP) | 2016-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160074856-A1 | RECOVERY METHOD AND REUSE METHOD OF OXO ACID CATALYST | HAO2, HAO1, AOX1 | HTT 1843/4885DNM1 1555/4885KMT2A 3612/4885 |
| US-20170044179-A1 | ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE THEREOF | DHCR7, HSD17B7, CYP17A1 | HTT 4066/4885DNM1 834/4885KMT2A 4118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.